Design and Synthesis of 3-Carbamoylbenzoic Acid Derivatives as Inhibitors of Human Apurinic/Apyrimidinic Endonuclease 1 (APE1)
作者:Francesca Aiello、Yumna Shabaik、Adrian Esqueda、Tino W. Sanchez、Fedora Grande、Antonio Garofalo、Nouri Neamati
DOI:10.1002/cmdc.201200334
日期:2012.10
catalytic endonuclease function of APE1 that contain a 3‐carbamoylbenzoic acid scaffold. Further structural modifications were made with the aim of increasing the activity and cytotoxicity of these inhibitors. Several of our compounds were shown to inhibit the catalytic endonuclease function of APE1 with potencies in the low‐micromolar range in vitro, and therefore represent novel classes of APE1 inhibitors
apurinic / apyrimidinic(AP)核酸内切酶1(APE1)是一个多方面的蛋白质,在碱基切除修复(BER)途径中起着至关重要的作用。它已在多种癌症中证实了其在肿瘤发展,进展和耐药性中的作用,使其成为进行深入研究的可行目标。在这项工作中,我们设计并合成了包含3个氨基甲酰基苯甲酸支架的APE1催化内切核酸酶功能的不同类别的小分子抑制剂。为了增加这些抑制剂的活性和细胞毒性,进行了进一步的结构修饰。我们的几种化合物显示出在体外在低微摩尔范围内抑制APE1的催化核酸内切酶功能的能力,因此代表了值得进一步开发的新型APE1抑制剂。